Precision Pharmacotherapy Smoking Cessation Program

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 23, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Smoking Cessation
Interventions
BEHAVIORAL

Standard Care

Participants will be advised to quit smoking and offered a choice of nicotine replacement patches or varenicline. Participants are free to decline medication.

BEHAVIORAL

Precision pharmacotherapy

Participants will be advised to quit smoking and provided a medication recommendation on the basis of their nicotine metabolite ratio (NMR) test (i.e., nicotine replacement patches for slower metabolizers, varenicline for faster metabolizers). Participants are free to choose either medication or decline any medication.

Trial Locations (1)

19713

Helen F. Graham Cancer Center & Research Institute, Newark

All Listed Sponsors
collaborator

University of Delaware

OTHER

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Christiana Care Health Services

OTHER